Table 2 Characteristics of patient cohorts from countries which contributed more than 3% of the study population
Country | Number of patients | Withhold LST (%) | Withdraw LST (%) | Number of patients in specific phenotypes (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | ||||
1 | 217 | 69 (32) | 26 (12) | 26 (12) | 60 (28) | 28 (13) | 32 (15) | 37 (17) | 18 (8) | 16 (7) |
2 | 205 | 20 (10) | 13 (6) | 61 (30) | 57 (28) | 20 (10) | 28 (14) | 30 (15) | 9 (4) | 0 (0) |
3 | 138 | 26 (19) | 11 (8) | 49 (36) | 25 (18) | 4 (3) | 28 (20) | 12 (9) | 19 (14) | 1 (1) |
4 | 105 | 60 (57) | 14 (13) | 30 (29) | 26 (25) | 4 (4) | 31 (30) | 10 (10) | 3 (3) | 1 (1) |
5 | 92 | 19 (21) | 4 (4) | 2 (2) | 5 (5) | 3 (3) | 21 (23) | 9 (10) | 2 (2) | 50 (54) |
6 | 79 | 35 (44) | 6 (8) | 6 (8) | 6 (8) | 16 (20) | 21 (27) | 5 (6) | 17 (22) | 8 (10) |
7 | 76 | 13 (17) | 7 (9) | 18 (24) | 10 (13) | 10 (13) | 8 (11) | 8 (11) | 11 (14) | 11 (14) |
8 | 64 | 11 (17) | 6 (9) | 6 (9) | 15 (23) | 10 (16) | 16 (25) | 5 (8) | 5 (8) | 7 (11) |
9 | 55 | 5 (9) | 0 (0) | 5 (9) | 4 (7) | 5 (9) | 14 (25) | 2 (4) | 1 (2) | 24 (44) |
10 | 54 | 28 (52) | 5 (9) | 8 (15) | 12 (22) | 9 (17) | 15 (28) | 6 (11) | 3 (6) | 1 (2) |